» Articles » PMID: 6604883

Involvement of 5-HT2 Receptors in the Wet-dog Shake Behaviour Induced by 5-hydroxytryptophan in the Rat

Overview
Specialties Neurology
Pharmacology
Date 1983 Jul 1
PMID 6604883
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The wet-dog shake behaviour induced by 5-hydroxytryptophan (5-HTP) was used as a model of central 5-hydroxytryptamine (5-HT) receptor activity in the rat. The wet-dog shake behaviour induced by 5-HTP was dose-dependent. Selective 5-HT2 receptor antagonists ketanserin, pirenperone and methysergide (with little selectivity) were administered to rats displaying the wet-dog shake behaviour. The three antagonists produced a rapid and dose-dependent inhibition of wet-dog shakes. Pirenperone was more potent than ketanserin, which was more potent than methysergide at inhibiting wet-dog shake behaviour. Since 5-HT2 receptor antagonists inhibit the 5-HTP-induced wet-dog shakes it is proposed that the wet-dog shakes induced by 5-HTP are mediated by activation of 5-HT2 receptors.

Citing Articles

C-LTMRs evoke wet dog shakes via the spinoparabrachial pathway.

Zhang D, Turecek J, Choi S, Delisle M, Pamplona C, Meltzer S Science. 2024; 386(6722):686-692.

PMID: 39509513 PMC: 11753759. DOI: 10.1126/science.adq8834.


5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology.

Maffei M Int J Mol Sci. 2020; 22(1).

PMID: 33375373 PMC: 7796270. DOI: 10.3390/ijms22010181.


Changes in the sexual behavior and testosterone levels of male rats in response to daily interactions with estrus females.

Shulman L, Spritzer M Physiol Behav. 2014; 133:8-13.

PMID: 24813700 PMC: 4084521. DOI: 10.1016/j.physbeh.2014.05.001.


The loss of methyl-CpG binding protein 1 leads to autism-like behavioral deficits.

Allan A, Liang X, Luo Y, Pak C, Li X, Szulwach K Hum Mol Genet. 2008; 17(13):2047-57.

PMID: 18385101 PMC: 2700628. DOI: 10.1093/hmg/ddn102.


Nalfurafine, the kappa opioid agonist, inhibits icilin-induced wet-dog shakes in rats and antagonizes glutamate release in the dorsal striatum.

Werkheiser J, Rawls S, Cowan A Neuropharmacology. 2006; 52(3):925-30.

PMID: 17150231 PMC: 1890045. DOI: 10.1016/j.neuropharm.2006.10.010.